Hudson Avenue Partners (“Hudson Avenue”) is pleased to announce that Trinity Hunt Partners (“Trinity Hunt”) has acquired Centricity Research, a leading North American provider of clinical research services for Phase I – IV clinical trials with expertise across diverse therapeutic specialties
Hudson Avenue acted as exclusive financial advisor to Trinity Hunt in arranging debt financing to support the acquisition and future growth capital needs of the platform
Centricity Research is a fully centralized Integrated Research Organization (IRO) specializing in conducting Phase I-IV clinical trials across more than 40 therapeutic areas. The company was formed in 2021 through the integration of multiple clinical research businesses across North America. It has completed more than 2,500 studies and has over 100 FDA and Health Canada Drug Approvals.
For additional information, visit www.centricityresearch.com
Trinity Hunt Partners is a growth-oriented private equity firm with over $1.7 billion of assets under management focused on building leading business, healthcare and consumer services companies. Trinity Hunt has earned a reputation for providing the strategic, operational and financial capabilities needed to take entrepreneurial services companies to the next level.
For additional information, visit www.trinityhunt.com